Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative)	1 Months Ended	12 Months Ended
	Oct. 31, 2023 USD ($)	Dec. 31, 2024 USD ($) Customer	Dec. 31, 2023 USD ($) Customer
Federal deposit insurance limit		$ 250,000
Cash held by subsidiaries		1,512,000	$ 1,963,000
Cash equivalents		0	0
Fair value liability		0	$ 0
Fair value liability transfers into level 3		0
Fair value liability transfers out of level 3		0
Fair value liability level 1 to level 2 transfers amount		0
Fair value liability level 2 to level 1 transfers amount		$ 0
Ownership percentage of acquisition	51.00%	51.00%	51.00%
Provision for income taxes	$ 0	$ 111,449	$ (6,133)
Liability for uncertain tax positions		0
Unrecognized tax benefits		0
Unrecognized tax benefits, penalties		0
Allowance for expected credit losses		0	0
Inventory		65,655	0
Net Income (Loss) Attributable to Parent		32,400,000	16,300,000
Cash and cash equivalents		61,900,000
Impairment losses of long-lived assets		0	0
Gain (loss) on asset acquisition		0
Revenues		$ 4,144,226	$ 433,026
Revenues [Member]
Number of customers | Customer		1	0
Customer One [Member] | Revenues [Member] | Concentrations of Credit Risk [Member]
Concentration risk percentage		14.00%
Revenues		$ 592,000
Customer [Member] | Revenues [Member] | Concentrations of Credit Risk [Member]
Concentration risk percentage			10.00%
Convertible Notes Payable [Member]
Fair value on a recurring basis		$ 33,433,184
Enlightened Isotopes [Member]
Subsidiary ownership percentage		80.00%
PET Labs Pharmaceuticals [Member]
Subsidiary ownership percentage		51.00%
P E T Labs [Member]
Subsidiary ownership percentage		51.00%
VIE ASP Rentals [Member]
Subsidiary ownership percentage		42.00%
Minimum [Member] | Property and equipment [Member]
Estimated useful lives		3 years
Maximum [Member] | Property and equipment [Member]
Estimated useful lives		10 years